Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Oct 1;102(10):926-928.
doi: 10.1097/PHM.0000000000002272. Epub 2023 Apr 25.

What Are the Effects of Treatments for Sialorrhea in People With Motor Neuron Disease/Amyotrophic Lateral Sclerosis?: A Cochrane Review Summary With Commentary

Affiliations
Comment

What Are the Effects of Treatments for Sialorrhea in People With Motor Neuron Disease/Amyotrophic Lateral Sclerosis?: A Cochrane Review Summary With Commentary

Matteo Johann Del Furia et al. Am J Phys Med Rehabil. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article.

Comment on

References

    1. James E, Ellis C, Brassington R, et al.: Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis. Cochrane Database Sys Rev 2022;5:CD006981
    1. Van Es MA, Hardiman O, Chio A, et al.: Amyotrophic lateral sclerosis. Lancet 2017;390:2084–98
    1. Simonds AK: Progress in respiratory management of bulbar complications of motor neuron disease/amyotrophic lateral sclerosis? Thorax 2017;72:199–201
    1. Morgante F, Bavikatte G, Anwar F, et al.: The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®). Ther Adv Neurol Disord 2019;12:1756286419888601
    1. Garuti G, Rao F, Ribuffo V, et al.: Sialorrhea in patients with ALS: current treatment options. Degener Neurol Neuromuscul Dis 2019;9:19–26

MeSH terms

LinkOut - more resources